
Efficacy of montelukas in the prevention of acute asthma episode in children
ZHU Ming-Liang, HE Shuo
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (08) : 695-696.
Efficacy of montelukas in the prevention of acute asthma episode in children
[1]全国儿科哮喘防治协作组.儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751.
[2]陈育智,赵京.儿童支气管哮喘的诊断及治疗[M].北京:人民卫生出版社,2004,1.
[3]郑春盛,林青,林莉婷,江敏.小儿哮喘与白三烯关系的研究[J].福建医药杂志,2003,25(3):167-168.
[4]岳孟源,肖洁,王薇.儿童慢性轻度哮喘治疗的临床研究[J].上海医学,2004,27(7):500-501.
[5]National Heart, Lung, and Blood Institute National Institutes of Health. Global Strategy for Asthma Management and Prevention[EB/OL].[2008-12-01].http://www.ginasthma.com/guidelineitem.asp?intid=82.
[6]何庆娟,肖钦志,吴惠芳.孟鲁司特钠治疗咳嗽变异性哮喘效果观察[J].南通大学学报(医学版), 2007, 27(6):535-537.
[7]杨红,高华.顺尔宁治疗小儿哮喘51例[J].第四军医大学学报,2005,26(13):1188.
[8]王成林,龚放,黄兆敏,黄瑛.孟鲁司特钠佐治哮喘38例疗效观察[J].实用儿科临床杂志, 2004, 19(10):885-886.
[9]Kleinman R, Mura M, Liu MY. 半胱氨酰白三烯拮抗剂治疗儿童哮喘[J].中国当代儿科杂志, 2005, 7(5):398-403.
[10]金耀建,宋志燕,胡野,钱旭波,王晓杨,何旭瑛.孟鲁司特和卡介苗多糖核酸对哮喘大鼠血单个核细胞中心TAT5B mRNA和II-4 mRNA表达的影响[J].中国当代儿科杂志,2009,11(2):133-137.